ArticleRevista medica del Instituto Mexicano del Seguro Social2025
[Epidemiological surveillance at IMSS: a review of institutional successes].
Article in Revista medica del Instituto Mexicano del Seguro Social, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Mexican Institute for Social Security (IMSS) has recently celebrated 8 decades of existence; its contribution to the processes of medical care, public health and epidemiological surveillance in Mexico have been among its cornerstones. This article presents some selected points of the history of the Institute's epidemiological surveillance, from its birth in the organic structure to the successes of identifying agents and responding to outbreaks, epidemics and pandemics that have been milestones in the modern history of our country, such as diseases preventable by vaccination, pathologies affecting the respiratory tract, as well as the gastrointestinal tract, vector-borne and sexually transmitted diseases that have been subject to sectoral epidemiological surveillance, not only in terms of epidemiological surveillance, but also as contributions of research. Finally, it is a brief recapitulation to know and understand the events that the Institute have experienced, i. e., where we come from, what has been achieved in order to understand where we are and what can be built and done in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.